Delta-Fly Pharma Inc
TSE:4598
Net Margin
Delta-Fly Pharma Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | JP |
Market Cap | 4.8B JPY |
Net Margin | N/A |
Country | US |
Market Cap | 293.9B USD |
Net Margin |
11%
|
Country | US |
Market Cap | 167.6B USD |
Net Margin |
13%
|
Country | US |
Market Cap | 115B USD |
Net Margin |
39%
|
Country | US |
Market Cap | 108.2B USD |
Net Margin |
29%
|
Country | AU |
Market Cap | 135.3B AUD |
Net Margin |
17%
|
Country | US |
Market Cap | 84.4B USD |
Net Margin |
2%
|
Country | US |
Market Cap | 50.9B USD |
Net Margin |
-116%
|
Country | US |
Market Cap | 43.1B USD |
Net Margin |
-33%
|
Country | US |
Market Cap | 33.6B USD |
Net Margin |
12%
|
Country | KR |
Market Cap | 39.7T KRW |
Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Delta-Fly Pharma Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Delta-Fly Pharma Inc's most recent financial statements, the company has Net Margin of 0%.